2010
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell. 2010;18(6):568-79.
Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. Blood Coagul Fibrinolysis. 2010;21(1):11-5.
Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010;6(4):551-62.
Gammopathy-associated acrosclerosis as a cause of flexion contractures in an older adult patient: a case report and literature review. Adv Skin Wound Care. 2010;23(1):25-8.
NBR1 is a new PB1 signalling adapter in Th2 differentiation and allergic airway inflammation in vivo. EMBO J. 2010;29(19):3421-33.
PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell. 2010;17(5):497-509.
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes. Cancer Epidemiol Biomarkers Prev. 2010;19(8):2088-96.
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant. 2010;10(3):464-71.